432 3-year results of the phase 2 randomized trial for talimogene laherparepvec (T-VEC) neoadjuvant treatment plus surgery vs surgery in patients with resectable stage IIIB-IVM1a m...

by Merrick Ross, Reinhard Dummer, Lev Demidov, Edward Chan, David Gyorki, Robert Conry, Hoi-Shen Radcliffe
Published 2020-11-01

Control and Toxicity in Melanoma Versus Other Brain Metastases in Response to Combined Radiosurgery and PD-(L)1 Immune Checkpoint Inhibition

by Roman L. Travis, BS, Samuel R. Marcrom, MD, Matthew H. Brown, BS, Mayank P. Patel, MD, James M. Markert, MD, MPH, Kristen O. Riley, MD, Robert Conry, MD, Christopher D. Willey, MD, PhD, Markus Bredel, MD, PhD, John B. Fiveash, MD
Published 2021-01-01

Pimasertib Versus Dacarbazine in Patients With Unresectable <i>NRAS</i>-Mutated Cutaneous Melanoma: Phase II, Randomized, Controlled Trial with Crossover

by Celeste Lebbé, Caroline Dutriaux, Thierry Lesimple, Willem Kruit, Joseph Kerger, Luc Thomas, Bernard Guillot, Filippo de Braud, Claus Garbe, Jean-Jacques Grob, Carmen Loquai, Virginia Ferraresi, Caroline Robert, Paul Vasey, Robert Conry, Richard Isaacs, Enrique Espinosa, Armin Schueler, Giorgio Massimini, Brigitte Dréno
Published 2020-06-01